Ortho Clinical Diagnostics (NASDAQ:OCDX – Get Rating) and VolitionRx (NYSE:VNRX – Get Rating) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.
Earnings & Valuation
This table compares Ortho Clinical Diagnostics and VolitionRx’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Ortho Clinical Diagnostics||$2.04 billion||1.92||-$54.30 million||($0.01)||-1,761.24|
This table compares Ortho Clinical Diagnostics and VolitionRx’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Ortho Clinical Diagnostics||-0.02%||41.71%||5.10%|
This is a summary of current ratings and target prices for Ortho Clinical Diagnostics and VolitionRx, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Ortho Clinical Diagnostics||0||3||4||0||2.57|
Ortho Clinical Diagnostics currently has a consensus target price of $23.95, suggesting a potential upside of 35.83%. Given Ortho Clinical Diagnostics’ higher probable upside, equities analysts clearly believe Ortho Clinical Diagnostics is more favorable than VolitionRx.
Risk and Volatility
Ortho Clinical Diagnostics has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, VolitionRx has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.
Institutional & Insider Ownership
11.1% of VolitionRx shares are owned by institutional investors. 15.4% of VolitionRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Ortho Clinical Diagnostics beats VolitionRx on 7 of the 13 factors compared between the two stocks.
About Ortho Clinical Diagnostics (Get Rating)
Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.
About VolitionRx (Get Rating)
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Ortho Clinical Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Clinical Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.